CANNABIS INNOVATION

Developing highly bioavailable botanical products through proprietary live plant extraction processes & technologies for the legal cannabis industry.

Pioneering Cannabis Medicine

Protext is a biotech company developing a comprehensive cannabis medicines platform for the legal cannabis industry, utilizing proprietary live plant extraction processes and cutting-edge technologies.

Road Map
Investor Relations
Discover our innovation

Learn more about our research, leadership, and investment opportunities in the cannabis medicine industry.

Investors
Investor Relations
Leadership Team
Publications
COMPANY STRUCTURE

Protext is a subsidiary of RSAMMD Acquisitions LLC, jointly owned by two principals: Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen (“Dr. J”).

Technology

Proprietary Extraction

Advanced live plant extraction processes designed for maximum bioavailability and therapeutic efficacy.

Innovation

Scientific Research

Rigorous testing and development of botanical products for pharmaceutical applications.

Excellence

Bioavailability Focus

Enhanced absorption and effectiveness through cutting-edge formulation techniques.

Sustainability

Natural Ingredients

All-natural, sustainable cannabis-based solutions for nutraceutical and medical applications.

Join the Future of
Cannabis Medicine

Be part of our mission to revolutionize botanical medicine
through innovative extraction technologies and scientific research.

Contact us
Investor Relations